Inventor
TACHIBANA TATSUHIKO
JP22 patents
⚠️ This page may combine multiple inventors who share the name “TACHIBANA TATSUHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
13 patentsUS9828429B2Nov 28, 2017
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD40 citations98
US11248053B2Feb 15, 2022
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD16 citations94
US10662245B2May 26, 2020
Methods of reducing IL-6 activity for disease treatment
CHUGAI PHARMACEUTICAL CO LTD22 citations94
US10519229B2Dec 31, 2019
Nucleic acids encoding IL-8 antibodies
CHUGAI PHARMACEUTICAL CO LTD22 citations93
US9399680B2Jul 26, 2016
Nucleic acids encoding anti-NR10 antibodies
CHUGAI PHARMACEUTICAL CO LTD17 citations91
US12122840B2Oct 22, 2024
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD5 citations86
US12116414B2Oct 15, 2024
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD5 citations86
US11718678B2Aug 8, 2023
Method for altering plasma retention and immunogenicity of antigen-binding molecule
CHUGAI PHARMACEUTICAL CO LTD7 citations85
US11180548B2Nov 23, 2021
Methods of neutralizing IL-8 biological activity
CHUGAI PHARMACEUTICAL CO LTD6 citations83
US10556949B2Feb 11, 2020
Antigen-binding molecule inducing immune response to target antigen
CHUGAI PHARMACEUTICAL CO LTD8 citations83
US9556264B2Jan 31, 2017
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
CHUGAI PHARMACEUTICAL CO LTD5 citations70
US12473375B2Nov 18, 2025
Methods for controlling blood pharmacokinetics of antibodies
CHUGAI PHARMACEUTICAL CO LTD0 citations62
US12371485B2Jul 29, 2025
Antigen-binding molecule inducing immune response to target antigen
CHUGAI PHARMACEUTICAL CO LTD0 citations62
IGAWA TOMOYUKI
5 patentsUS9096651B2Aug 4, 2015
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
IGAWA TOMOYUKI90 citations99
US8562991B2Oct 22, 2013
Antibody molecules that bind to IL-6 receptor
IGAWA TOMOYUKI130 citations98
US11046784B2Jun 29, 2021
Methods for controlling blood pharmacokinetics of antibodies
IGAWA TOMOYUKI24 citations94
US10618965B2Apr 14, 2020
Method for altering plasma retention and immunogenicity of antigen-binding molecule
IGAWA TOMOYUKI32 citations93
US8497355B2Jul 30, 2013
Anti-glypican-3 antibody having improved kinetics in plasma
IGAWA TOMOYUKI29 citations92